Personalis (PSNL) Stock Forecast, Price Target & Predictions
PSNL Stock Forecast
Personalis stock forecast is as follows: an average price target of $7.75 (represents a 36.20% upside from PSNL’s last price of $5.69) and a rating consensus of 'Hold', based on 17 wall street analysts offering a 1-year stock forecast.
PSNL Price Target
PSNL Analyst Ratings
Personalis Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 19, 2024 | Thomas Flaten | Lake Street | $8.00 | $5.91 | 35.36% | 40.60% |
Aug 19, 2024 | Swayampakula Ramakanth | H.C. Wainwright | $9.00 | $5.99 | 50.25% | 58.17% |
Aug 16, 2024 | Mark Massaro | BTIG | $7.00 | $5.99 | 16.86% | 23.02% |
Aug 08, 2024 | Mark Massaro | BTIG | $5.50 | $3.43 | 60.35% | -3.34% |
Aug 08, 2024 | Mike Matson | Needham | $5.50 | $2.88 | 90.97% | -3.34% |
Jun 21, 2024 | Mike Matson | Needham | $3.50 | $1.22 | 186.89% | -38.49% |
Apr 30, 2024 | Thomas Flaten | Loop Capital Markets | $4.00 | $1.47 | 172.11% | -29.70% |
May 06, 2022 | - | Morgan Stanley | $13.00 | $5.16 | 151.94% | 128.47% |
Personalis Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 3 | 6 | 7 |
Avg Price Target | $8.00 | $6.42 | $6.07 |
Last Closing Price | $5.69 | $5.69 | $5.69 |
Upside/Downside | 40.60% | 12.83% | 6.68% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 19, 2024 | Lake Street | Buy | Buy | Hold |
Aug 19, 2024 | BTIG | Underperform | Underperform | Hold |
Aug 19, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 08, 2024 | BTIG | Buy | Buy | Hold |
Aug 08, 2024 | Needham | Buy | Buy | Hold |
Jun 21, 2024 | Needham | Buy | Buy | Hold |
May 09, 2024 | Needham | Buy | Buy | Hold |
May 09, 2024 | Lake Street | Underperform | Underperform | Hold |
Apr 30, 2024 | Lake Street | - | Buy | Initialise |
Feb 24, 2023 | Wedbush | Buy | Buy | Hold |
Personalis Financial Forecast
Personalis Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $18.25M | - | $18.86M | $16.72M | $14.86M | - | $15.23M | $20.68M | $22.26M | $21.67M | $20.88M | $20.18M | $19.82M | $19.50M | $19.16M | $18.15M | $17.15M |
Avg Forecast | $27.33M | $28.54M | $29.09M | $24.43M | $25.95M | $24.79M | $21.03M | $17.88M | $16.47M | $21.33M | $19.27M | $18.37M | $19.63M | $16.98M | $16.49M | $17.35M | $16.72M | $13.99M | $15.51M | $14.34M | $20.52M | $22.24M | $21.21M | $20.43M | $20.02M | $18.99M | $16.33M | $17.20M | $17.91M | $15.77M |
High Forecast | $27.82M | $29.05M | $29.61M | $24.86M | $26.41M | $25.23M | $21.40M | $18.20M | $16.76M | $22.06M | $19.61M | $18.70M | $19.98M | $17.28M | $16.79M | $17.66M | $17.02M | $14.24M | $15.51M | $14.69M | $21.02M | $22.78M | $21.72M | $20.93M | $20.51M | $19.45M | $16.73M | $17.62M | $18.35M | $16.15M |
Low Forecast | $27.05M | $28.25M | $28.79M | $24.18M | $25.68M | $24.53M | $20.81M | $17.69M | $16.30M | $20.12M | $19.07M | $18.18M | $19.43M | $16.80M | $16.32M | $17.17M | $16.55M | $13.84M | $15.51M | $13.96M | $19.98M | $21.65M | $20.64M | $19.89M | $19.49M | $18.49M | $15.90M | $16.74M | $17.44M | $15.35M |
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | - | 1.09% | 1.00% | 1.06% | - | 1.06% | 1.01% | 1.00% | 1.02% | 1.02% | 1.01% | 1.04% | 1.19% | 1.11% | 1.01% | 1.09% |
Personalis EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-30.79M | - | $-21.93M | $-31.01M | $-24.55M | - | $-26.37M | $-18.54M | $-16.09M | $-13.49M | $-10.79M | $-11.77M | $-7.96M | $-7.59M | $-7.71M | $-4.70M | $-5.49M |
Avg Forecast | $-19.42M | $-20.28M | $-20.67M | $-17.36M | $-18.44M | $-17.61M | $-14.94M | $-12.70M | $-11.70M | $-15.16M | $-13.69M | $-38.56M | $-13.95M | $-12.06M | $-11.72M | $-30.48M | $-11.88M | $-17.70M | $-11.02M | $-24.10M | $-20.40M | $-16.09M | $-15.22M | $-12.89M | $-9.74M | $-8.24M | $-8.70M | $-6.48M | $-12.73M | $-6.15M |
High Forecast | $-19.22M | $-20.07M | $-20.46M | $-17.18M | $-18.25M | $-17.43M | $-14.79M | $-12.57M | $-11.58M | $-14.30M | $-13.55M | $-30.85M | $-13.80M | $-11.94M | $-11.60M | $-24.38M | $-11.76M | $-14.16M | $-11.02M | $-19.28M | $-16.32M | $-12.88M | $-12.18M | $-10.31M | $-7.79M | $-6.59M | $-6.96M | $-5.18M | $-12.39M | $-4.92M |
Low Forecast | $-19.77M | $-20.64M | $-21.04M | $-17.67M | $-18.76M | $-17.93M | $-15.21M | $-12.93M | $-11.91M | $-15.68M | $-13.93M | $-46.27M | $-14.19M | $-12.28M | $-11.93M | $-36.58M | $-12.09M | $-21.24M | $-11.02M | $-28.91M | $-24.48M | $-19.31M | $-18.27M | $-15.46M | $-11.69M | $-9.89M | $-10.44M | $-7.77M | $-13.04M | $-7.38M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.55% | - | 0.72% | 2.61% | 1.39% | - | 1.09% | 0.91% | 1.00% | 0.89% | 0.84% | 1.21% | 0.97% | 0.87% | 1.19% | 0.37% | 0.89% |
Personalis Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | - | - |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-29.10M | - | $-28.66M | $-31.07M | $-26.49M | - | $-28.21M | $-20.20M | $-17.67M | $-14.95M | $-12.40M | $-13.34M | $-9.54M | $-9.26M | $-9.14M | $-6.64M | $-6.88M |
Avg Forecast | $-21.02M | $-22.12M | $-22.70M | $-19.03M | $-13.28M | $-16.65M | $-18.23M | $-18.56M | $-19.39M | $-18.34M | $-19.56M | $-41.25M | $-26.20M | $-27.19M | $-28.10M | $-32.61M | $-33.82M | $-19.44M | $-29.56M | $-25.78M | $-22.22M | $-17.67M | $-16.87M | $-14.82M | $-11.04M | $-9.89M | $-10.62M | $-7.68M | $-12.52M | $-7.71M |
High Forecast | $-20.73M | $-21.82M | $-22.39M | $-18.77M | $-13.10M | $-16.43M | $-17.99M | $-18.31M | $-19.13M | $-13.89M | $-19.30M | $-33.00M | $-21.25M | $-26.82M | $-27.72M | $-26.09M | $-33.36M | $-15.55M | $-29.56M | $-20.62M | $-17.78M | $-14.14M | $-13.50M | $-11.85M | $-8.83M | $-7.91M | $-8.49M | $-6.14M | $-12.09M | $-6.17M |
Low Forecast | $-21.50M | $-22.63M | $-23.22M | $-19.47M | $-13.58M | $-17.04M | $-18.65M | $-18.99M | $-19.84M | $-22.78M | $-20.01M | $-49.50M | $-31.14M | $-27.82M | $-28.75M | $-39.13M | $-34.60M | $-23.32M | $-29.56M | $-30.93M | $-26.66M | $-21.20M | $-20.24M | $-17.78M | $-13.25M | $-11.86M | $-12.74M | $-9.21M | $-12.92M | $-9.25M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | - | 0.88% | 0.92% | 1.36% | - | 1.09% | 0.91% | 1.00% | 0.89% | 0.84% | 1.21% | 0.97% | 0.87% | 1.19% | 0.53% | 0.89% |
Personalis SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | - | - |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.97M | - | $14.10M | $17.83M | $14.78M | - | $15.49M | $13.71M | $12.14M | $11.43M | $10.42M | $10.92M | $7.79M | $7.71M | $7.27M | $6.39M | $6.06M |
Avg Forecast | $16.32M | $17.04M | $17.37M | $14.58M | $15.49M | $14.80M | $12.55M | $10.67M | $9.83M | $12.73M | $11.50M | $10.97M | $11.72M | $10.14M | $9.85M | $10.36M | $9.98M | $13.35M | $9.26M | $14.15M | $15.08M | $12.14M | $12.89M | $12.45M | $9.04M | $8.07M | $8.84M | $6.11M | $10.69M | $6.78M |
High Forecast | $16.61M | $17.34M | $17.68M | $14.84M | $15.77M | $15.06M | $12.78M | $10.86M | $10.01M | $13.17M | $11.71M | $11.16M | $11.93M | $10.32M | $10.02M | $10.54M | $10.16M | $16.02M | $9.26M | $16.98M | $18.10M | $14.57M | $15.47M | $14.94M | $10.84M | $9.69M | $10.61M | $7.33M | $10.96M | $8.14M |
Low Forecast | $16.15M | $16.86M | $17.19M | $14.43M | $15.33M | $14.65M | $12.42M | $10.56M | $9.73M | $12.01M | $11.38M | $10.85M | $11.60M | $10.03M | $9.75M | $10.25M | $9.88M | $10.68M | $9.26M | $11.32M | $12.06M | $9.71M | $10.31M | $9.96M | $7.23M | $6.46M | $7.07M | $4.89M | $10.41M | $5.43M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.18% | - | 1.36% | 1.79% | 1.11% | - | 1.09% | 0.91% | 1.00% | 0.89% | 0.84% | 1.21% | 0.97% | 0.87% | 1.19% | 0.60% | 0.89% |
Personalis EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | - | - |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.60 | - | $-0.61 | $-0.67 | $-0.58 | - | $-0.63 | $-0.45 | $-0.40 | $-0.34 | $-0.29 | $-0.38 | $-0.27 | $-0.29 | $-0.29 | $-0.21 | $-0.22 |
Avg Forecast | $-0.40 | $-0.42 | $-0.43 | $-0.36 | $-0.25 | $-0.32 | $-0.35 | $-0.35 | $-0.37 | $-0.35 | $-0.37 | $-0.41 | $-0.50 | $-0.52 | $-0.54 | $-0.58 | $-0.65 | $-0.62 | $-0.58 | $-0.58 | $-0.50 | $-0.42 | $-0.39 | $-0.36 | $-0.29 | $-0.28 | $-0.34 | $-0.26 | $-0.25 | $-0.25 |
High Forecast | $-0.40 | $-0.42 | $-0.43 | $-0.36 | $-0.25 | $-0.31 | $-0.34 | $-0.35 | $-0.37 | $-0.27 | $-0.37 | $-0.40 | $-0.41 | $-0.51 | $-0.53 | $-0.58 | $-0.64 | $-0.62 | $-0.58 | $-0.56 | $-0.48 | $-0.41 | $-0.37 | $-0.35 | $-0.28 | $-0.27 | $-0.33 | $-0.25 | $-0.24 | $-0.24 |
Low Forecast | $-0.41 | $-0.43 | $-0.44 | $-0.37 | $-0.26 | $-0.33 | $-0.36 | $-0.36 | $-0.38 | $-0.43 | $-0.38 | $-0.42 | $-0.59 | $-0.53 | $-0.55 | $-0.60 | $-0.66 | $-0.64 | $-0.58 | $-0.60 | $-0.51 | $-0.44 | $-0.40 | $-0.37 | $-0.29 | $-0.29 | $-0.35 | $-0.26 | $-0.26 | $-0.26 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | - | 1.05% | 1.04% | 0.93% | - | 1.09% | 0.91% | 0.94% | 0.88% | 0.81% | 1.32% | 0.97% | 0.85% | 1.14% | 0.83% | 0.89% |
Personalis Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
DRIO | DarioHealth | $0.95 | $10.75 | 1031.58% | Buy |
STIM | Neuronetics | $0.73 | $8.00 | 995.89% | Buy |
GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
GH | Guardant Health | $26.79 | $57.27 | 113.77% | Buy |
CRL | Charles River Laboratories | $198.61 | $324.46 | 63.37% | Buy |
ILMN | Illumina | $129.18 | $200.82 | 55.46% | Buy |
PSNL | Personalis | $5.69 | $7.75 | 36.20% | Hold |
CSTL | Castle Biosciences | $31.18 | $38.00 | 21.87% | Buy |
CDNA | CareDx | $28.87 | $31.00 | 7.38% | Buy |
MYGN | Myriad Genetics | $27.59 | $27.67 | 0.29% | Hold |
NTRA | Natera | $126.51 | $114.38 | -9.59% | Buy |
TWST | Twist Bioscience | $46.95 | $41.20 | -12.25% | Buy |
PSNL Forecast FAQ
Is Personalis a good buy?
No, according to 17 Wall Street analysts, Personalis (PSNL) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 47.06% of PSNL's total ratings.
What is PSNL's price target?
Personalis (PSNL) average price target is $7.75 with a range of $4 to $13, implying a 36.20% from its last price of $5.69. The data is based on 17 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Personalis stock go up soon?
According to Wall Street analysts' prediction for PSNL stock, the company can go up by 36.20% (from the last price of $5.69 to the average price target of $7.75), up by 128.47% based on the highest stock price target, and down by -29.70% based on the lowest stock price target.
Can Personalis stock reach $9?
PSNL's highest twelve months analyst stock price target of $13 supports the claim that Personalis can reach $9 in the near future.
What is Personalis's current price target trend?
3 Wall Street analysts forecast a $8 price target for Personalis (PSNL) this month, up 40.60% from its last price of $5.69. Compared to the last 3 and 12 months, the average price target increased by 12.83% and increased by 6.68%, respectively.
What are Personalis's analysts' financial forecasts?
Personalis's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $89.64M (high $91.24M, low $88.72M), average EBITDA is $-63.691M (high $-63.034M, low $-64.826M), average net income is $-66.715M (high $-65.82M, low $-68.261M), average SG&A $53.52M (high $54.47M, low $52.96M), and average EPS is $-1.273 (high $-1.256, low $-1.303). PSNL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $109.4M (high $111.35M, low $108.27M), average EBITDA is $-77.73M (high $-76.928M, low $-79.115M), average net income is $-84.858M (high $-83.72M, low $-86.825M), average SG&A $65.31M (high $66.48M, low $64.64M), and average EPS is $-1.62 (high $-1.598, low $-1.657).
Did the PSNL's actual financial results beat the analysts' financial forecasts?
Based on Personalis's last annual report (Dec 2022), the company's revenue was $65.05M, beating the average analysts forecast of $60.56M by 7.42%. Apple's EBITDA was $-113M, beating the average prediction of $-64.697M by 74.77%. The company's net income was $-113M, beating the average estimation of $-109M by 4.35%. Apple's SG&A was $63.97M, beating the average forecast of $46.75M by 36.85%. Lastly, the company's EPS was $-2.48, beating the average prediction of $-2.431 by 2.02%. In terms of the last quarterly report (Sep 2023), Personalis's revenue was $18.25M, beating the average analysts' forecast of $16.98M by 7.47%. The company's EBITDA was $-30.793M, beating the average prediction of $-12.063M by 155.26%. Personalis's net income was $-29.098M, beating the average estimation of $-27.188M by 7.03%. The company's SG&A was $11.97M, beating the average forecast of $10.14M by 18.10%. Lastly, the company's EPS was $-0.6, beating the average prediction of $-0.519 by 15.63%